COF vs EDIT · P/E 62, rev $53.43B vs rev $32.3M
Capital One Financial Corporation (COF) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
Capital One Financial Corporation (COF) is a credit services company listed on NYSE.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported COF revenue for 2025-12-31 was $53.43B. Net income was $2.45B. Revenue was up 36.6% from 2024-12-31 to 2025-12-31. COF currently screens at market cap $125.00B and trailing P/E 61.8.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
COF currently screens at market cap $125.00B and trailing P/E 61.8. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the COF and EDIT stock pages for the full models.
Not investment advice.